259 related articles for article (PubMed ID: 9734404)
1. Expression of heme oxygenase-1 can determine cardiac xenograft survival.
Soares MP; Lin Y; Anrather J; Csizmadia E; Takigami K; Sato K; Grey ST; Colvin RB; Choi AM; Poss KD; Bach FH
Nat Med; 1998 Sep; 4(9):1073-7. PubMed ID: 9734404
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants.
Sato K; Balla J; Otterbein L; Smith RN; Brouard S; Lin Y; Csizmadia E; Sevigny J; Robson SC; Vercellotti G; Choi AM; Bach FH; Soares MP
J Immunol; 2001 Mar; 166(6):4185-94. PubMed ID: 11238670
[TBL] [Abstract][Full Text] [Related]
3. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor.
Kobayashi T; Taniguchi S; Ye Y; Niekrasz M; Kosanke S; Neethling FA; Wright LJ; Rose AG; White DJ; Cooper DK
Transplant Proc; 1996 Apr; 28(2):560. PubMed ID: 8623270
[No Abstract] [Full Text] [Related]
4. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
[TBL] [Abstract][Full Text] [Related]
5. Accommodation after lung xenografting from hamster to rat.
Tabata T; de Perrot M; Keshavjee S; Liu M; Downey GP; Waddell TK
Transplantation; 2003 Mar; 75(5):607-12. PubMed ID: 12640297
[TBL] [Abstract][Full Text] [Related]
6. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
[TBL] [Abstract][Full Text] [Related]
7. Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts.
Koyamada N; Miyatake T; Candinas D; Mark W; Hechenleitner P; Hancock WW; Soares MP; Bach FH
Transplantation; 1998 May; 65(9):1210-5. PubMed ID: 9603170
[TBL] [Abstract][Full Text] [Related]
8. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients.
Miyatake T; Koyamada N; Hancock WW; Soares MP; Bach FH
Transplantation; 1998 Jun; 65(12):1563-9. PubMed ID: 9665071
[TBL] [Abstract][Full Text] [Related]
9. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
[TBL] [Abstract][Full Text] [Related]
10. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.
Araujo JA; Meng L; Tward AD; Hancock WW; Zhai Y; Lee A; Ishikawa K; Iyer S; Buelow R; Busuttil RW; Shih DM; Lusis AJ; Kupiec-Weglinski JW
J Immunol; 2003 Aug; 171(3):1572-80. PubMed ID: 12874251
[TBL] [Abstract][Full Text] [Related]
11. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation.
Candinas D; Lesnikoski BA; Robson SC; Scesney SM; Otsu I; Myiatake T; Marsh HC; Ryan US; Hancock WW; Bach FH
Transplant Proc; 1996 Apr; 28(2):581. PubMed ID: 8623282
[No Abstract] [Full Text] [Related]
12. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine.
Scheringa M; Schraa EO; Bouwman E; van Dijk H; Melief MJ; Ijzermans JN; Marquet RL
Transplantation; 1995 Dec; 60(11):1350-3. PubMed ID: 8525534
[No Abstract] [Full Text] [Related]
13. Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide.
Brouard S; Cuturi MC; Pignon P; Buelow R; Loth P; Moreau A; Soulillou JP
Transplantation; 1999 Jun; 67(12):1614-8. PubMed ID: 10401770
[TBL] [Abstract][Full Text] [Related]
14. Induction of xenograft accommodation by modulation of elicited antibody responses1 2.
Wang N; Lee JM; Tobiasch E; Csizmadia E; Smith NR; Gollackes B; Robson SC; Bach FH; Lin Y
Transplantation; 2002 Aug; 74(3):334-45. PubMed ID: 12177611
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 as a protective gene.
Bach FH
Wien Klin Wochenschr; 2002; 114 Suppl 4():1-3. PubMed ID: 15499991
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats.
Fryer JP; Chen S; Johnson EM; Simone P; Sun LH; Goswitz JJ; Matas AJ
Transplant Proc; 1996 Apr; 28(2):700. PubMed ID: 8623353
[No Abstract] [Full Text] [Related]
17. Complement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantation.
Oh JY; Kim MK; Lee HJ; Ko JH; Kim Y; Park CS; Kang HJ; Park CG; Kim SJ; Lee JH; Wee WR
Xenotransplantation; 2010; 17(2):140-6. PubMed ID: 20522246
[TBL] [Abstract][Full Text] [Related]
18. Suppression of T cells results in long-term survival of mouse heart xenografts in C6-deficient rats.
Wu G; Korsgren O; van Rooijen N; Tibell A
Xenotransplantation; 2001 Nov; 8(4):303-9. PubMed ID: 11737856
[TBL] [Abstract][Full Text] [Related]
19. The effect of MX-1 on survival of discordant cardiac xenografts from guinea pig to rat.
Kaji H; Platt JL; Sutherland DE; Inoue K; Mori C; Shiota K; Imamura M
Transpl Immunol; 1997 Mar; 5(1):70-2. PubMed ID: 9106338
[No Abstract] [Full Text] [Related]
20. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.
Kobayashi T; Taniguchi S; Neethling FA; Rose AG; Hancock WW; Ye Y; Niekrasz M; Kosanke S; Wright LJ; White DJ; Cooper DK
Transplantation; 1997 Nov; 64(9):1255-61. PubMed ID: 9371665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
